140 related articles for article (PubMed ID: 35283244)
1. Prevalence and clinical features of herpes simplex virus infection in oral lesions of pemphigus vulgaris: A prospective, cross-sectional study.
Zhang H; Wang Y; Li S; Yu M; Feng S
J Am Acad Dermatol; 2022 Nov; 87(5):1201-1203. PubMed ID: 35283244
[No Abstract] [Full Text] [Related]
2. Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations.
Caldarola G; Kneisel A; Hertl M; Feliciani C
Eur J Dermatol; 2008; 18(4):440-3. PubMed ID: 18573719
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus.
Baum S; Atar I; Coster D; Dovrat S; Solomon M; Sprecher E; Zeeli T; Barzilai A
Acta Derm Venereol; 2022 May; 102():adv00703. PubMed ID: 35393625
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
Carew B; Wagner G
Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
[TBL] [Abstract][Full Text] [Related]
6. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
7. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
[TBL] [Abstract][Full Text] [Related]
8. ELISA detection of anti-desmoglein 1 and anti-desmoglein 3 and indirect immunofluorescence in oral pemphigus: A retrospective study.
Petruzzi M; Lucchese A; Contaldo M; Tampoia M; Frassanito MA; Lauritano D; Della Vella F
Oral Dis; 2022 May; 28(4):1149-1156. PubMed ID: 33721369
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Pemphigus vulgaris and herpes simplex virus infection in oral mucosa diagnosed by cytology, immunohistochemistry, and polymerase chain reaction.
Takahashi I; Kobayashi TK; Suzuki H; Nakamura S; Tezuka F
Diagn Cytopathol; 1998 Dec; 19(6):446-50. PubMed ID: 9839135
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Pemphigus Vulgaris Showing a Local Nose Erosion as the First Clinical Manifestation].
Kaneoka A; Sawada Y
J UOEH; 2022; 44(2):215-219. PubMed ID: 35660688
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against desmoglein 2 are not pathogenic in pemphigus.
Miguel MCB; Julio TA; Vernal S; de Paula NA; Lieber A; Roselino AM
An Bras Dermatol; 2022; 97(2):145-156. PubMed ID: 35058080
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.
Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D
Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and clinical features of pemphigus vulgaris.
Venugopal SS; Murrell DF
Immunol Allergy Clin North Am; 2012 May; 32(2):233-43, v-vi. PubMed ID: 22560136
[TBL] [Abstract][Full Text] [Related]
16. Neonatal pemphigus vulgaris.
Gushi M; Yamamoto Y; Mine Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Uezato H
J Dermatol; 2008 Aug; 35(8):529-35. PubMed ID: 18789074
[TBL] [Abstract][Full Text] [Related]
17. Identification of factors associated with treatment refractoriness of oral lesions in pemphigus vulgaris.
Kumar S; De D; Handa S; Ratho RK; Bhandari S; Pal A; Kamboj P; Sarkar S
Br J Dermatol; 2017 Dec; 177(6):1583-1589. PubMed ID: 28498563
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous type of pemphigus vulgaris.
Gheisari M; Shahidi-Dadras M; Nasiri S; Dargah SM; Dadkhahfar S; Abdollahimajd F
J Am Acad Dermatol; 2020 Sep; 83(3):919-920. PubMed ID: 31931088
[No Abstract] [Full Text] [Related]
19. Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.
Belloni-Fortina A; Faggion D; Pigozzi B; Peserico A; Bordignon M; Baldo V; Alaibac M
Clin Dev Immunol; 2009; 2009():187864. PubMed ID: 20049340
[TBL] [Abstract][Full Text] [Related]
20. Detection of herpes simplex viruses in the oral lesions of patients with pemphigus vulgaris: Is it diagnostic or predictive of disease severity?
Kamyab K; Daneshpazhooh M; Zaresharifi N; Ghanadan A; Shahsiah R; Mahmoudi HR; Zaresharifi S
Skin Health Dis; 2023 Oct; 3(5):e261. PubMed ID: 37799351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
